{"id":231288,"date":"2026-02-13T13:10:32","date_gmt":"2026-02-13T19:10:32","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/02\/creating-car-t-cells-using-current-alzheimers-antibodies"},"modified":"2026-02-13T13:10:32","modified_gmt":"2026-02-13T19:10:32","slug":"creating-car-t-cells-using-current-alzheimers-antibodies","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/02\/creating-car-t-cells-using-current-alzheimers-antibodies","title":{"rendered":"Creating CAR-T Cells Using Current Alzheimer\u2019s Antibodies"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/creating-car-t-cells-using-current-alzheimers-antibodies.jpg\"><\/a><\/p>\n<p>A team of researchers has <a href=\"https:\/\/www.pnas.org\/doi\/10.1073\/pnas.2530977123\">biologically engineered T cells with currently available Alzheimer\u2019s drugs in order to directly attack the characteristic amyloid plaques of Alzheimer\u2019s disease<\/a>.<\/p>\n<p><b><b>Building on the current paradigm<\/b><\/b><\/p>\n<p>Most Alzheimer\u2019s treatments used in the clinic are-mabs, monoclonal antibodies that are designed to attack the amyloid beta plaques that accumulate in the brains of people with Alzheimer\u2019s. However, while they have been found to have enough meaningful benefits in clinical trials to be approved by the FDA, they are not a cure, and some analyses question their effectiveness [1].<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A team of researchers has biologically engineered T cells with currently available Alzheimer\u2019s drugs in order to directly attack the characteristic amyloid plaques of Alzheimer\u2019s disease. Building on the current paradigm Most Alzheimer\u2019s treatments used in the clinic are-mabs, monoclonal antibodies that are designed to attack the amyloid beta plaques that accumulate in the brains [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1902,11,47],"tags":[],"class_list":["post-231288","post","type-post","status-publish","format-standard","hentry","category-bioengineering","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/231288","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=231288"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/231288\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=231288"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=231288"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=231288"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}